Berapakah harga Rhinomed Limited (RNO)

Harga Rhinomed Limited (RNO) adalah $0.0260778

Apakah topi pasaran Rhinomed Limited (RNO)

Cap pasaran Rhinomed Limited (RNO) adalah $3.69M

Rhinomed Limited (RNO) Pecahan Saham

Headquartered in Cremorne, Australia, Rhinomed Limited is a global enterprise dedicated to the research, development, and market introduction of consumer and medical devices. Since its incorporation in 2004, the company has focused on creating wearable nasal technologies designed to optimize breathing, improve sleep quality, support general health, and assist in disease diagnosis. Its product offerings include the Turbine, which enhances athletic breathing; Mute, aimed at reducing snoring and promoting clearer airflow; Pronto, a vapor inhaler developed to aid airflow and sleep; and Rhinoswab, utilized for efficient nasal sample collection. Beyond these products, Rhinomed is actively engaged in developing programs across diverse fields such as sleep architecture, the cognitive impact of sleep and respiratory function, obstructive sleep apnea, pain and nausea relief, respiratory diseases, and advanced diagnostics and sensors. The company also provides a distinct drug delivery platform specifically for cannabinoid formulations. Formerly known as Consegna Group Limited, the company adopted the name Rhinomed Limited in November 2013.

Tahun	Pecahan	Gandaan	Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.

Tahun

Pecahan

Gandaan

Gandaan Kumulatif

Tidak cukup data untuk tarikh yang disediakan.

Syarikat	Bilangan pecahan saham	Gandaan Kumulatif	Negara
Abbott Laboratories ABT.US	9	x285	US
Stryker Corporation SYK.US	9	x162	US
Medtronic plc MDT.US	7	x127	IE
Boston Scientific Corporation BSX.US	2	x4	US
Edwards Lifesciences Corporation EW.US	3	x12	US

Syarikat

Bilangan pecahan saham

Gandaan Kumulatif

Negara